Impact of iron treatment on immune effector function and cellular iron status of circulating monocytes in dialysis patients

Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications

(2009) I. Theurl et al.   BLOOD

Slc11a1 limits intracellular growth ofSalmonella entericasv. Typhimurium by promoting macrophage immune effector functions and impairing bacterial iron acquisition

(2009) Manfred Nairz et al.   CELLULAR MICROBIOLOGY

Erythropoietin Therapy and Left Ventricular Mass Index in CKD and ESRD Patients: A Meta-Analysis

(2009) P. S. Parfrey et al.   Clinical Journal of the American Society of Nephrology

Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy

(2009) G. Weiss et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Serum Prohepcidin and Hepcidin in Hemodialyzed Patients Undergoing Iron Therapy

(2009) Jolanta Malyszko et al.   KIDNEY & BLOOD PRESSURE RESEARCH

The Role of Hepcidin in Iron Homeostasis and Anemia in Hemodialysis Patients

(2009) Theodoros Eleftheriadis et al.   SEMINARS IN DIALYSIS

Quantification of Hepcidin-25 in Human Serum by Isotope Dilution Micro-HPLC-Tandem Mass Spectrometry

(2008) U. Kobold et al.   CLINICAL CHEMISTRY

Variability of ferritin measurements in chronic kidney disease; implications for iron management

(2008) Bradley A. Ford et al.   KIDNEY INTERNATIONAL

Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease?

(2008) D. W. Swinkels et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION